Welcome!

News Feed Item

New Online Tool Helps Patient Advocates Navigate Medicines Development and Evaluation Process

INDIANAPOLIS, March 24, 2014 /PRNewswire/ --



A new online, interactive training programme designed to help patient advocates better influence decisions related to access to new medicines was launched today in advance of the 6th  Global  Patient  Congress at Ascot, United Kingdom.

Developed by Eli Lilly and Company in collaboration with internationally renowned experts in the fields of patient involvement and health technology assessment (HTA), the eMEET (Medicine Evaluation Educational Training) online resource is a unique tool designed to help patient advocates navigate the complex world of medicines development, evaluation and assessment. eMEET is endorsed by Health Technology Assessment International (HTAi), the global scientific and professional society for those who produce, use, or encounter HTA.[1]

"The growing role of patient engagement in the medicines evaluation process is one of the key drivers to improving access - and patient advocates have much to contribute," commented clinical expert Professor Ken Paterson, Former Chair, Scottish Medicines Consortium. "By helping ensure patients have a voice, it's a win for the healthcare system, a win for the HTA process and most importantly, a win for patients."

Patients have unique knowledge about what it's like to live with an illness, the possible limitations of existing treatments and the potential of new therapies. However, ensuring that patients' experiences are considered can be challenging in an environment where decisions are scientifically based.

"It's absolutely crucial that patient advocates understand the medicine development and HTA processes. Advocates can then make a more robust contribution to the medicines evaluation discussion and be accepted as an equal and knowledgeable stakeholder in healthcare decisions," said Kathy Oliver, Co-director for the International Brain Tumour Alliance (IBTA). "eMEET is a great resource. It's easily accessible online, you can learn at your own pace, and it's an enjoyable and valuable educational tool."

eMEET uses a variety of tools, such as video presentations, animations and exercises to show how patients' experiences can be integrated into these complex processes. The programme helps patient advocates ensure, in the most productive and meaningful way, that their input to the medicines evaluation process successfully highlights patient issues, informs decision-making and aligns with the scientific evidence.

"Evidence from patients can help us understand the challenges associated with current therapies and what they would want from new treatments," said Dr. Karen Facey, HTAi Interest Group for Patient/Citizen involvement in HTA. "This can help us put the scientific evidence into context and understand the true value of a treatment."

The eMEET training programme is presented in modules focused on:

  1. Introduction  and  scene-setting  - the  true  value  of  the  patient  voice
  2. The  journey  of  a  medicine - the  complex  process  of  medicines  discovery,  development  and  evaluation
  3. An  introduction  to  HTA
  4. HTA  in  practice - an  illustration  of  the  complexities  of  health  technology  assessment
  5. Patient  advocacy  group  participation  in  HTA  - how  to  engage  effectively  to  ensure  that  HTA  panels  understand  patients'  needs  and  preferences

eMEET is the online component of the broader MEET programme. Translated into multiple languages, MEET was developed as an interactive one-day training workshop designed to help patient advocacy group leaders understand and engage in the journey of a medicine, including: clinical trials, regulatory evaluation and HTA. eMEET does not focus on any specific disease state. MEET and eMEET are part of the advocacy component of PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative. For more information, please visit http://www.meetforpatients.com.

To view the multi-media press release, including the MEET video testimonials, eMEET teaser video and eMEET brochure please click the link below.

www.epresspack.net/mmr/news/5296

About  HTA

According to Health Technology Assessment International's "HTAi Patient and Consumer Glossary," health technology assessment is the "systematic evaluation of the clinical effectiveness and/or cost-effectiveness and/or the social and ethical impact of a health technology" (such as a medicine) "on the lives of patients and the healthcare system." Its aim is to educate healthcare policymakers. HTA organisations, such as NICE (National Institute for Health and Care Excellence) in the United Kingdom, recommend whether a specific health technology should be used, and if so, in which setting and for which patients. According to the glossary, "assessments vary, but most look at the health benefits and risks of using the technology. They also look at costs and any wider impacts that the technology might have on a population or on society."[2]

About  PACE 

Created by Lilly Oncology as a global collaboration spanning diverse sectors, PACE (Patient Access to Cancer care Excellence) exists to encourage public policies and healthcare decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. PACE is engaging key oncology stakeholders: patients, advocacy, payers, policymakers, providers, the public, researchers and politicians. To learn more about PACE and the PACE  Cancer  Perception  Index, please visit http://www.pacenetwork.com.

About  Lilly  Oncology

For more than fifty years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly's commitment to people with cancer, please visit http://www.LillyOncology.com.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at http://www.lilly.com and http://newsroom.lilly.com/social-channels.

References:

1. Health Technology Assessment International. What is HTAi? Available at http://www.htai.org/index.php?id=428. Accessed 21 March 2014.

2. Health Technology Assessment International. HTAi Patient and Consumer Glossary: A beginner’s guide to words used in health technology assessment. October 2009. Available at http://www.ihe.ca/documents/HTAiPatientAndConsumerGlossaryOctober2009_01.pdf. Accessed 21 March 2014.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Cloud-enabled transformation has evolved from cost saving measure to business innovation strategy -- one that combines the cloud with cognitive capabilities to drive market disruption. Learn how you can achieve the insight and agility you need to gain a competitive advantage. Industry-acclaimed CTO and cloud expert, Shankar Kalyana presents. Only the most exceptional IBMers are appointed with the rare distinction of IBM Fellow, the highest technical honor in the company. Shankar has also receive...
"With Digital Experience Monitoring what used to be a simple visit to a web page has exploded into app on phones, data from social media feeds, competitive benchmarking - these are all components that are only available because of some type of digital asset," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at DevOps Summit at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
What's the role of an IT self-service portal when you get to continuous delivery and Infrastructure as Code? This general session showed how to create the continuous delivery culture and eight accelerators for leading the change. Don Demcsak is a DevOps and Cloud Native Modernization Principal for Dell EMC based out of New Jersey. He is a former, long time, Microsoft Most Valuable Professional, specializing in building and architecting Application Delivery Pipelines for hybrid legacy, and cloud ...
"I focus on what we are calling CAST Highlight, which is our SaaS application portfolio analysis tool. It is an extremely lightweight tool that can integrate with pretty much any build process right now," explained Andrew Siegmund, Application Migration Specialist for CAST, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
"We view the cloud not as a specific technology but as a way of doing business and that way of doing business is transforming the way software, infrastructure and services are being delivered to business," explained Matthew Rosen, CEO and Director at Fusion, in this SYS-CON.tv interview at 18th Cloud Expo (http://www.CloudComputingExpo.com), held June 7-9 at the Javits Center in New York City, NY.
"We were founded in 2003 and the way we were founded was about good backup and good disaster recovery for our clients, and for the last 20 years we've been pretty consistent with that," noted Marc Malafronte, Territory Manager at StorageCraft, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
The Founder of NostaLab and a member of the Google Health Advisory Board, John is a unique combination of strategic thinker, marketer and entrepreneur. His career was built on the "science of advertising" combining strategy, creativity and marketing for industry-leading results. Combined with his ability to communicate complicated scientific concepts in a way that consumers and scientists alike can appreciate, John is a sought-after speaker for conferences on the forefront of healthcare science,...
WebRTC is great technology to build your own communication tools. It will be even more exciting experience it with advanced devices, such as a 360 Camera, 360 microphone, and a depth sensor camera. In his session at @ThingsExpo, Masashi Ganeko, a manager at INFOCOM Corporation, introduced two experimental projects from his team and what they learned from them. "Shotoku Tamago" uses the robot audition software HARK to track speakers in 360 video of a remote party. "Virtual Teleport" uses a multip...
"Software-defined storage is a big problem in this industry because so many people have different definitions as they see fit to use it," stated Peter McCallum, VP of Datacenter Solutions at FalconStor Software, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York City, NY.
As you move to the cloud, your network should be efficient, secure, and easy to manage. An enterprise adopting a hybrid or public cloud needs systems and tools that provide: Agility: ability to deliver applications and services faster, even in complex hybrid environments Easier manageability: enable reliable connectivity with complete oversight as the data center network evolves Greater efficiency: eliminate wasted effort while reducing errors and optimize asset utilization Security: implemen...
Data is the fuel that drives the machine learning algorithmic engines and ultimately provides the business value. In his session at Cloud Expo, Ed Featherston, a director and senior enterprise architect at Collaborative Consulting, discussed the key considerations around quality, volume, timeliness, and pedigree that must be dealt with in order to properly fuel that engine.
In his session at Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, presented a success story of an entrepreneur who has both suffered through and benefited from offshore development across multiple businesses: The smart choice, or how to select the right offshore development partner Warning signs, or how to minimize chances of making the wrong choice Collaboration, or how to establish the most effective work processes Budget control, or how to maximize project result...
"DivvyCloud as a company set out to help customers automate solutions to the most common cloud problems," noted Jeremy Snyder, VP of Business Development at DivvyCloud, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
CI/CD is conceptually straightforward, yet often technically intricate to implement since it requires time and opportunities to develop intimate understanding on not only DevOps processes and operations, but likely product integrations with multiple platforms. This session intends to bridge the gap by offering an intense learning experience while witnessing the processes and operations to build from zero to a simple, yet functional CI/CD pipeline integrated with Jenkins, Github, Docker and Azure...
"Our strategy is to focus on the hyperscale providers - AWS, Azure, and Google. Over the last year we saw that a lot of developers need to learn how to do their job in the cloud and we see this DevOps movement that we are catering to with our content," stated Alessandro Fasan, Head of Global Sales at Cloud Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.